Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: equity fund investors

equity fund investors

posted on Jul 22, 2008 12:04PM

From experience, the above will only invest at a discount to the prevailing market price. I would sooner a commercial loan at up to 12% over prime was taken out, fairly easy given the stated solid cash position, and wait for appreciation in share price before issuing further stock.

There is absolutely no reason to place shares at these acknowledged depressed prices without there being a conflict to the overriding fiduciary duty, in my very humble opinion.





Be well

Share
New Message
Please login to post a reply